Surrey Heartlands

Joint Formulary & PAD

Levocarnitine - Metabolic disorders

You are here : Home > Formulary Search > Levocarnitine - Metabolic disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
R
Restrictions / Comments :
 

Status 2

Red
Formulations :
  • Oral solution
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
R
Restrictions / Comments :
Important

30% paediatric solution (1.5 gram in 5ml)

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Levocarnitine
Indication :
Metabolic disorders
Group Name :
Keywords :
carnitine deficiency, L-carnitine, Urea cycle disorders
Brand Names Include :
Important Information :

NHSE specialised commissioned services only. Not commissioned from any acute Trust in Surrey Heartlands.

However, this drug may be used in the emergency treatment of urea cycle disorders in patients on acute admission

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Levocarnitine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Metabolic disorders.

Committee Recommendations (0)

  • No records returned.